Utama › Leukemia › California › Los Angeles
Kajian klinikal Leukemia di Los Angeles, CA
16 kajian untuk Leukemia sedang mencari peserta di lokasi dalam dan sekitar Los Angeles (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Mengambil pesertaFasa 3
- Quetzal Site 7, Los Angeles
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Mengambil pesertaFasa 2
- USC Norris Comprehensive Cancer Center, Los Angeles
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Mengambil pesertaFasa 2
- UCLA Medical Center, Los Angeles
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Children s Hospital of Los Angeles, Los Angeles
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Mengambil pesertaFasa 3
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles, Los Angeles
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Mengambil pesertaFasa 1
- USC Norris Comprehensive Cancer Center, Los Angeles
- UCLA Health - Bowyer Oncology Center, Los Angeles
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Mengambil pesertaFasa 2
- Children's Hospital Los Angeles, Los Angeles
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Mengambil pesertaFasa 1/2
- Research Site, Los Angeles
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Mengambil pesertaFasa 1/2
- Valkyrie Clinical Trials, Los Angeles
Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Mengambil pesertaFasa 1/2
- David Geffen School of Medicine at the University of California at Los Angeles, Los Angeles
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Mengambil pesertaFasa 2
- UCLA Department of Medicine, Los Angeles
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Mengambil pesertaFasa 2/3
- Keck School of Medicine of USC, Los Angeles
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Mengambil pesertaFasa 1/2
- Los Angeles Cancer Network, Los Angeles
- UCLA Medical Center of Hematology/Oncology, Los Angeles
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Mengambil pesertaFasa 1
- USC / Norris Comprehensive Cancer Center, Los Angeles
- UCLA - Bowyer Oncology Center, Los Angeles
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Mengambil pesertaFasa 1
- University of California Los Angeles, Los Angeles
Effects of Using a Storybook, to Explain Leukemia to Children Versus the Standard Child Life Intervention, on Parental Stress.
Mengambil pesertaSukarelawan sihat dialu-alukan
- Children's Hospital Los Angeles, Los Angeles
Kajian Leukemia di bandar lain
- Houston, TX28 kajian
- Boston, MA25 kajian
- New York City, NY19 kajian
- Chicago, IL16 kajian
- Durham, NC13 kajian
- Columbus, OH12 kajian
- Baldwin Park, CA12 kajian
- Nashville, TN12 kajian
- Philadelphia, PA12 kajian
- Milwaukee, WI11 kajian
- Atlanta, GA11 kajian
- Seattle, WA11 kajian
Kajian lain di Los Angeles
- Kanser Paru-paru Bukan Sel Kecil87 kajian
- Kanser (semua jenis)73 kajian
- Kanser Payudara72 kajian
- Kanser Prostat61 kajian
- Kanser Kolorektal59 kajian
- Kanser Metastatik57 kajian
- Kanser Ovari50 kajian
- Kanser Paru-paru45 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher42 kajian
- Kanser Pankreas35 kajian
- Kanser Endometrium34 kajian
- Melanoma34 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.